149 related articles for article (PubMed ID: 36591704)
21. Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase.
Ceyhun İ; Karaca Ş; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100372. PubMed ID: 34893996
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular docking of new acridine-coumarin hybrids.
Hamulakova S; Janovec L; Soukup O; Jun D; Kuca K
Int J Biol Macromol; 2017 Nov; 104(Pt A):333-338. PubMed ID: 28601645
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and Molecular Docking of New Bis-Thiazolidinone-Based Chalcone Analogs as Effective Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Hussain R; Rahim F; Rehman W; Taha M; Khan S; Zaman K; Adnan Ali Shah S; Wadood A; Imran S; Abdellatif MH
Chem Biodivers; 2022 Oct; 19(10):e202200323. PubMed ID: 35997224
[TBL] [Abstract][Full Text] [Related]
24. Docking-based design and synthesis of galantamine-camphane hybrids as inhibitors of acetylcholinesterase.
Stavrakov G; Philipova I; Zheleva-Dimitrova D; Valkova I; Salamanova E; Konstantinov S; Doytchinova I
Chem Biol Drug Des; 2017 Nov; 90(5):709-718. PubMed ID: 28374576
[TBL] [Abstract][Full Text] [Related]
25. Novel Potent and Selective Acetylcholinesterase Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease: Synthesis, Pharmacological Evaluation, and Molecular Modeling of Amino-Alkyl-Substituted Fluoro-Chalcones Derivatives.
Liu HR; Zhou C; Fan HQ; Tang JJ; Liu LB; Gao XH; Wang QA; Liu WK
Chem Biol Drug Des; 2015 Oct; 86(4):517-22. PubMed ID: 25588967
[TBL] [Abstract][Full Text] [Related]
26. Chemical library design, QSAR modeling and molecular dynamics simulations of naturally occurring coumarins as dual inhibitors of MAO-B and AChE.
Boulaamane Y; Kandpal P; Chandra A; Britel MR; Maurady A
J Biomol Struct Dyn; 2024; 42(4):1629-1646. PubMed ID: 37199265
[TBL] [Abstract][Full Text] [Related]
27. Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease.
Bajad NG; Singh RB; T A G; Gutti G; Kumar A; Krishnamurthy S; Singh SK
Bioorg Chem; 2024 Feb; 143():107082. PubMed ID: 38199142
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the interactions between coumarin-derivatives and acetylcholinesterase: Examination by NMR and docking simulations.
Tanoli NU; Tanoli SAK; Ferreira AG; Mehmood M; Gul S; Monteiro JL; Vieira LCC; Venâncio T; Correa AG; Ul-Haq Z
J Mol Model; 2018 Jul; 24(8):207. PubMed ID: 30008113
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, biological evaluation, and molecular modeling studies of chalcone-rivastigmine hybrids as cholinesterase inhibitors.
Wang L; Wang Y; Tian Y; Shang J; Sun X; Chen H; Wang H; Tan W
Bioorg Med Chem; 2017 Jan; 25(1):360-371. PubMed ID: 27856236
[TBL] [Abstract][Full Text] [Related]
30. New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation.
Singh A; Sharma S; Arora S; Attri S; Kaur P; Kaur Gulati H; Bhagat K; Kumar N; Singh H; Vir Singh J; Mohinder Singh Bedi P
Bioorg Med Chem Lett; 2020 Oct; 30(20):127477. PubMed ID: 32781220
[TBL] [Abstract][Full Text] [Related]
31. Discovery of Novel Coumarin-Schiff Base Hybrids as Potential Acetylcholinesterase Inhibitors: Design, Synthesis, Enzyme Inhibition, and Computational Studies.
Hasan AH; Abdulrahman FA; Obaidullah AJ; Alotaibi HF; Alanazi MM; Noamaan MA; Murugesan S; Amran SI; Bhat AR; Jamalis J
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513883
[TBL] [Abstract][Full Text] [Related]
32. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations.
Zhang L; Li D; Cao F; Xiao W; Zhao L; Ding G; Wang ZZ
Comb Chem High Throughput Screen; 2018; 21(1):41-49. PubMed ID: 29173156
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of 4'-aminochalcone-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Xiao G; Li Y; Qiang X; Xu R; Zheng Y; Cao Z; Luo L; Yang X; Sang Z; Su F; Deng Y
Bioorg Med Chem; 2017 Feb; 25(3):1030-1041. PubMed ID: 28011206
[TBL] [Abstract][Full Text] [Related]
34. Novel coumarin-chalcone derivatives: Synthesis, characterization, antioxidant, cyclic voltammetry, molecular modelling and biological evaluation studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors.
Çelik Onar H; Özden EM; Taslak HD; Gülçin İ; Ece A; Erçağ E
Chem Biol Interact; 2023 Sep; 383():110655. PubMed ID: 37573926
[TBL] [Abstract][Full Text] [Related]
35. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
[TBL] [Abstract][Full Text] [Related]
36. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, docking study and biological evaluation of some novel tetrahydrochromeno [3',4':5,6]pyrano[2,3-b]quinolin-6(7H)-one derivatives against acetyl- and butyrylcholinesterase.
Khoobi M; Alipour M; Moradi A; Sakhteman A; Nadri H; Razavi SF; Ghandi M; Foroumadi A; Shafiee A
Eur J Med Chem; 2013 Oct; 68():291-300. PubMed ID: 23988412
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
Saeed A; Zaib S; Ashraf S; Iftikhar J; Muddassar M; Zhang KY; Iqbal J
Bioorg Chem; 2015 Dec; 63():58-63. PubMed ID: 26440714
[TBL] [Abstract][Full Text] [Related]
39. Anti-Cholinesterase Activity of Chalcone Derivatives: Synthesis, In Vitro Assay and Molecular Docking Study.
Riswanto FDO; Rawa MSA; Murugaiyah V; Salin NH; Istyastono EP; Hariono M; Wahab HA
Med Chem; 2021; 17(5):442-452. PubMed ID: 31808389
[TBL] [Abstract][Full Text] [Related]
40. Novel coumarin derivatives as potent acetylcholinesterase inhibitors: insight into efficacy, mode and site of inhibition.
Baruah P; Basumatary G; Yesylevskyy SO; Aguan K; Bez G; Mitra S
J Biomol Struct Dyn; 2019 Apr; 37(7):1750-1765. PubMed ID: 29663860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
